Situational analysis and future directions for medicine retail outlets: compliance with pharmaceutical regulatory standards in Ethiopia
- PMID: 40166068
- PMCID: PMC11956760
- DOI: 10.3389/fmed.2025.1452875
Situational analysis and future directions for medicine retail outlets: compliance with pharmaceutical regulatory standards in Ethiopia
Abstract
Background: Medicine regulation is essential for safeguarding the safety, efficacy, and quality of pharmaceutical products available in medicine retail outlets (MROs). It ensures that medicines, whether sourced locally or internationally, comply with stringent quality standards and regulatory protocols to protect public health. Effective regulation enhances trust in pharmaceutical markets by ensuring the availability of safe and effective medications. However, the regulatory framework within healthcare facilities, particularly in MROs where significant drug-related information is exchanged, is often underperforming. This issue is particularly pronounced in low-and middle-income countries like Ethiopia, where MROs play a critical role as the initial point of healthcare contact. This review aims to assess the level of compliance with pharmaceutical regulatory standards in medicine retail outlets (MROs) in Ethiopia and to evaluate the enforcement of these standards in the country's pharmaceutical market.
Methods: The review utilized online databases such as PubMed, and Web of Science to collect relevant studies and reports. It focused on issues of regulatory compliance in MROs in Ethiopia, identifying gaps in practice, drug quality, and adherence to national guidelines set by the Ethiopian Food and Drug Authority (EFDA).
Results: The review revealed significant regulatory compliance issues within Ethiopian MROs, leading to the distribution of poor quality medicines. It was found that drugs obtained from non-compliant outlets failed to meet quality control standards outlined in drug monographs. Many MROs and pharmacy professionals were found to be non-compliant with EFDA guidelines. Additionally, dispensing and storage practices in MROs were not in line with EFDA regulations and required improvements.
Conclusion: The review underlines the need for regulatory enforcement in Ethiopia health settings to address issues of non-compliance and the distribution of poor-quality drugs. It suggests that regulatory bodies should enhance inspection measures and provide opportunities for continued professional development for pharmacy staff and regulatory personnel. Collaboration among regulatory authorities, government, professionals, and academic researchers are pivotal to improving compliance and ensuring the availability of safe, effective, and quality medicines within medicine retail outlets and then protecting public health.
Keywords: EFDA; Ethiopia; compliance; medicine retail outlets; poor-quality drugs; regulatory standards; review.
Copyright © 2025 Mekasha, Getahun, Tegegne and Hasen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.Ethiop J Health Sci. 2016 May;26(3):259-76. doi: 10.4314/ejhs.v26i3.9. Ethiop J Health Sci. 2016. PMID: 27358547 Free PMC article.
-
Regulatory Compliance and Associated Quality of Amoxicillin in Drug Retail Outlets of Southwestern Ethiopia.Drug Healthc Patient Saf. 2021 Nov 30;13:241-249. doi: 10.2147/DHPS.S337791. eCollection 2021. Drug Healthc Patient Saf. 2021. PMID: 34876858 Free PMC article.
-
Traditional herbal medicine legislative and regulatory framework: a cross-sectional quantitative study and archival review perspectives.Front Pharmacol. 2025 Jan 30;16:1475297. doi: 10.3389/fphar.2025.1475297. eCollection 2025. Front Pharmacol. 2025. PMID: 39950109 Free PMC article.
-
No prescription? No problem: drivers of non-prescribed sale of antibiotics among community drug retail outlets in low and middle income countries: a systematic review of qualitative studies.BMC Public Health. 2021 Jun 3;21(1):1056. doi: 10.1186/s12889-021-11163-3. BMC Public Health. 2021. PMID: 34082726 Free PMC article.
-
Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities.J Pharm Policy Pract. 2023 May 2;16(1):60. doi: 10.1186/s40545-023-00557-w. J Pharm Policy Pract. 2023. PMID: 37131256 Free PMC article.
References
-
- Abedellah A, Noordin M, Zaki AA. Pharmaceutical good manufacturing practice regulatory affairs in Sudan: continuous debate between regulatory authority and manufacturers. Pharmaceut Reg Affairs. (2016) 5:2.
-
- Cohen-Kohler J, Baghdadi G. The world medicines situation 2011: good governance for the pharmaceutical sector. Geneva: World Health Organization; (2011).
-
- WHO . The safety of medicines in public health programmes. WHO: pharmacovigilance, an essential tool. (2006).
-
- Beardsley J, Chambers JM, Lam TT, Zawahir S, le H, Nguyen TA, et al. . Mapping access to drug outlets in Vietnam: distribution of drug outlets and the sociodemographic characteristics of the communities they serve. Lancet Reg Health West Pac. (2023) 30:100668. doi: 10.1016/j.lanwpc.2022.100668, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources